CA1128862A - Cephradine compositions and method - Google Patents

Cephradine compositions and method

Info

Publication number
CA1128862A
CA1128862A CA338,142A CA338142A CA1128862A CA 1128862 A CA1128862 A CA 1128862A CA 338142 A CA338142 A CA 338142A CA 1128862 A CA1128862 A CA 1128862A
Authority
CA
Canada
Prior art keywords
cephradine
water
arginine
milligrams per
per milliliter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA338,142A
Other languages
English (en)
French (fr)
Inventor
Anthony L. La Via
Irwin S. Gibbs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Application granted granted Critical
Publication of CA1128862A publication Critical patent/CA1128862A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
CA338,142A 1978-11-15 1979-10-22 Cephradine compositions and method Expired CA1128862A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US960,792 1978-11-15
US05/960,792 US4235900A (en) 1978-11-15 1978-11-15 Cephradine compositions

Publications (1)

Publication Number Publication Date
CA1128862A true CA1128862A (en) 1982-08-03

Family

ID=25503637

Family Applications (1)

Application Number Title Priority Date Filing Date
CA338,142A Expired CA1128862A (en) 1978-11-15 1979-10-22 Cephradine compositions and method

Country Status (10)

Country Link
US (1) US4235900A (en:Method)
JP (1) JPS5572109A (en:Method)
AU (1) AU536346B2 (en:Method)
BE (1) BE880043A (en:Method)
CA (1) CA1128862A (en:Method)
DE (1) DE2945387A1 (en:Method)
FR (1) FR2441387A1 (en:Method)
GB (1) GB2035801B (en:Method)
IT (1) IT1127227B (en:Method)
ZA (1) ZA795624B (en:Method)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES525492A0 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
CH660306A5 (de) * 1984-10-05 1987-04-15 Schering Spa Wasserloesliche pharmazeutische zusammensetzungen auf der basis von salzen der (-)cis-1,2-epoxypropylphosphonsaeure mit aminosaeuren.
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4994451A (en) * 1988-01-19 1991-02-19 Bristol-Myers Company Cephalosporin salts and injectable compositions
AT393452B (de) * 1985-08-05 1991-10-25 Bristol Myers Squibb Co Verfahren zur herstellung eines cephalosporinpraeparates zur herstellung einer injektionsloesung
US6225304B1 (en) 1999-02-17 2001-05-01 Pharmaceutical Solutions, Inc. Soluble forms of amoxicillin and treatment of animals
CN111595973A (zh) * 2020-05-30 2020-08-28 苏州必宜生物科技有限公司 一种液相色谱-串联质谱法测定血浆中头孢拉定浓度的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1291282A (en) * 1969-03-20 1972-10-04 Pfizer Ltd Improvements in pharmaceutical compositions
US3940483A (en) * 1971-02-05 1976-02-24 E. R. Squibb & Sons, Inc. Antibiotic compositions and method
US3984403A (en) * 1972-06-30 1976-10-05 Takeda Chemical Industries, Ltd. Arginine and lysine salts of acid cephalosporins
ES412429A1 (es) * 1973-03-08 1976-01-01 Gallardo Antonio Sa Un procedimiento para la obtencion de sales de antibioticoscon aminoacidos de naturaleza basica.

Also Published As

Publication number Publication date
ZA795624B (en) 1980-10-29
GB2035801A (en) 1980-06-25
DE2945387A1 (de) 1980-06-04
FR2441387A1 (fr) 1980-06-13
DE2945387C2 (en:Method) 1993-01-07
BE880043A (fr) 1980-05-14
FR2441387B1 (en:Method) 1983-01-07
IT7927288A0 (it) 1979-11-14
AU5206079A (en) 1980-05-22
GB2035801B (en) 1982-10-27
US4235900A (en) 1980-11-25
AU536346B2 (en) 1984-05-03
IT1127227B (it) 1986-05-21
JPS5572109A (en) 1980-05-30

Similar Documents

Publication Publication Date Title
US4064138A (en) Amino acid derivatives
EP0189941B1 (en) Antibiotic compositions
US3940483A (en) Antibiotic compositions and method
US3482025A (en) Glutathione-amino acid compositions,and glutathione-basic amino acid salts
SK24389A3 (en) Crystalline additive salts of 7-alpha[(2-aminothiazol-4-yl)- -alpha-(z)-methoxyiminoacetamido]-3-[(1-methyl-1- -pyrrolidino)methyl]-3-cephem-4-carboxylate, method for producing and pharmaceutical compositions comprising same
CA1128862A (en) Cephradine compositions and method
GB1489780A (en) Process of preparing a stable composition containing a compound of the prostaglandin e group
US3050445A (en) Stabilized trypsin solution
US5478829A (en) Solution of sparfloxacin, its preparation and salt of which it is composed
US4061744A (en) Stable preparation of water-soluble salts of dehydroepiandrosterone sulfate for parenteral administration
EP0386668B1 (en) Lyophilized dihydrochloride of 7-[alpha-(2-aminothiazol-4-yl)-alpha-(Z)-methoxyiminoacetamido]-3-[(1-methyl-1-pyrrolidinium)-methyl]-3-cephem-4-carboxylate
US5254545A (en) Injectable preparations containing cephalosporin medicament
EP0356143A1 (en) Injectable solutions
US3696195A (en) Stable aqueous steroid phosphate solutions
DE2617895A1 (de) Dispersion zur herstellung eines injizierbaren radiopharmazeutischen scanning-mittels
US2407412A (en) Therapeutic solutions
JP2708749B2 (ja) 修飾型ｔＰＡ含有注射用組成物
CA1308358C (en) Antibacterial lyophilized preparation
EP0029668B1 (en) Pharmaceutical injectable composition and two-pack container for said composition
US2388261A (en) Riboflavin solution
US5420124A (en) Stable, painless piroxicam potassium injectable composition
US3542929A (en) Chemotherapeutic compositions useful in animal detoxification
US2611732A (en) Compositions containing mixtures of 4-aminosalicylic acid and its basic calcium salt
US3133858A (en) Stable thiobarbituric acid solution
US4416874A (en) Injectable compositions of BBM-928A

Legal Events

Date Code Title Description
MKEX Expiry
MKEX Expiry

Effective date: 19990803